Generic Advair May Help COPD Costs, but Management is Tough

When high out-of-pocket costs spur noncompliance that leads to increased hospitalization, payers take notice. Using therapies for COPD as a case in point, AIS Health, Radar on Drug Benefits interviews Precision for Value Vice President, Access Experience, Charline Shan about the strategies payers may take to lower costs for their beneficiaries—and themselves.

LEARN MORE

Generic Advair May Help COPD Costs, but Management is Tough2020-03-13T15:14:26-04:00

Precision for Value Taps Payer Veterans to Join Market-Leading Access Experience Team

Precision for Value, part of Precision Value & Health, the market leader in supporting global pharmaceutical and life science companies in demonstrating the value and outcomes of innovative medical products, today announced further strategic expansion of its Access Experience Team with the hiring of former payer and integrated delivery network (IDN) decision makers Ryan Cox, Dan Danielson, and Erin Lopata.

LEARN MORE

Precision for Value Taps Payer Veterans to Join Market-Leading Access Experience Team2020-03-13T15:15:16-04:00
Precision Medicine Group

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC. All Rights Reserved.   Privacy | GDPR